The Effect of Cannabidiol 3% on Neuropsychiatric Symptoms in Dementia - Six-Month Follow-Up.

Alexandri, Foteini; Papadopoulou, Lydia; Tsolaki, Anthoula; Papantoniou, Georgia; Athanasiadis, Loukas; Tsolaki, Magda

Alexandri, Foteini; Papadopoulou, Lydia; Tsolaki, Anthoula; Papantoniou, Georgia; Athanasiadis, Loukas; Tsolaki, Magda.

Afiliación

Alexandri F; Neurosciences and Neurodegenerative Diseases, Postgraduate Course, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Greece.
Papadopoulou L; Neurosciences and Neurodegenerative Diseases, Postgraduate Course, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Greece.
Tsolaki A; Greek Association of Alzheimer's Disease and Related Disorders (Alzheimer Hellas), Thessaloniki, Greece.
Papantoniou G; 1st Department of Neurology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Greece.
Athanasiadis L; Department of Early Childhood Education, Faculty of Education Science, University of Ioannina, Ioannina, Greece.
Tsolaki M; 1st Department of Psychiatry, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Greece.

Clin Gerontol ; : 1-8, 2023 May 08.

Article en En | MEDLINE | ID: mdl-37153956

Palabras clave

Behavioral and Psychological symptoms of Dementia (BPSD); Cannabinoids; cannabidiol; dementia; neuropsychiatric symptoms

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Qualitative_research Idioma: En Revista: Clin Gerontol Año: 2023 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google